It's been a mediocre week for Alvotech ( NASDAQ:ALVO ) shareholders, with the stock dropping 17% to US$9.55 in the ...
Learn more about whether Alvotech or Grifols, S.A. is a better investment based on AAII's A+ Investor grades, which compare ...
Learn more about whether Alvotech or Vericel Corporation is a better investment based on AAII's A+ Investor grades, which ...
Spectrum Science, a 2024 MM+M Agency 100 honoree, hired Jill Beene as president of advertising and consulting, Lauren Ankeles as EVP of operations and transformation, as well as Natalie Newman as ...
Full Year 2024 Results Key Financial Results Revenue: US$492.0m (up 427% from FY 2023).
Northland Securities analyst Carl Byrnes maintained a Buy rating on Alvotech (ALVO – Research Report) today and set a price target of $28.00.
Alvotech (NASDAQ:ALVOW – Get Free Report) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 6,000 shares, a decline of 36.2% from ...
Co-production deals with adalimumab biosimilar manufacturers and PBMs have increased biosimilar adoption, but this ...
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Alvotech (Symbol: ALVO) entered into oversold territory, hitting an RSI reading of 24.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results